Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LCTX is expected to report earnings to fall 11.00% to -2 cents per share on November 05

Lineage Cell Therapeutics LCTX Stock Earnings Reports

Q3'26

Est.

$-0.03

Q2'26

Missed

by $0.01

Q1'26

Missed

by $0.02

Q4'25

Beat

by $0.05

Q3'25

Missed

by $0.11

The last earnings report on August 06 showed earnings per share of -2 cents, missing the estimate of -1 cents. With 913.45K shares outstanding, the current market capitalization sits at 255.44M.

View a ticker or compare two or three

LCTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for LCTX